# Cyprotex

the in-vitro ADMET and high-content-toxicology leader (Macclesfield, UK), now within Labcorp — its devTOX quickPredict human-iPSC developmental-toxicity assay and miniaturised 96-well CYP induction workflows were both presented in 2026,…

Source: https://en.bioecon.ru/companies/cyprotex/
Updated: 2026-08-15

- Country: United Kingdom

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Founded | 1999 | https://www.evotec.com/news/evotec-completes-acquisition-of-cyprotex-plc |
| Headquarters | United Kingdom | https://www.evotec.com/news/evotec-completes-acquisition-of-cyprotex-plc |
| Headcount | 136 employees as of December 2016 | https://www.evotec.com/news/evotec-completes-acquisition-of-cyprotex-plc |
| Production site | Macclesfield and Alderley Park, UK; Watertown, MA and Kalamazoo, MI, USA | https://www.evotec.com/news/evotec-completes-acquisition-of-cyprotex-plc |
| Regulatory approval | devTOX quickPredict has an FDA-agreed Context of Use statement and complies with ICH S5(R3) definitions | https://www.labcorp.com/education-events/articles/inside-preclinical-nams-innovation-qa-labcorp-experts-darren-kidd-and-jessica-palmer-devtox |

Independent sources: evotec.com, labcorp.com

## Technologies

- [Toxics screening (toxicomics, service)](https://en.bioecon.ru/technology/toxics-screening-toxicomics-service/)